Mary Lou McMaster is an American oncologist and clinical trialist who researches familial cancer genetics. She is a senior clinical trial specialist at the National Cancer Institute and a captain in the United States Public Health Service Commissioned Corps.
Mary L. McMaster | |
---|---|
Alma mater | Wake Forest School of Medicine |
Scientific career | |
Fields | Cancer genetics, oncology, clinical trials |
Institutions | National Cancer Institute |
Life
editMcMaster received her M.D. from the Wake Forest School of Medicine.[1] She completed residency training in internal medicine and a fellowship in medical oncology at Vanderbilt University.[1] Following a postdoctoral fellowship in cellular biology at the UNC Lineberger Comprehensive Cancer Center, she came to the National Institutes of Health (NIH), where she completed training in clinical medical genetics.[1]
McMaster joined the National Cancer Institute (NCI) as a clinical research fellow in the then-genetic epidemiology branch in the division of cancer epidemiology and genetics.[1] She researched cancer genetics with an emphasis on familial cancer syndromes.[1] McMaster was promoted to staff clinician in 2002, and transferred to the clinical genetics branch (CGB) in 2016.[1] She is a commissioned officer in the United States Public Health Service Commissioned Corps and was promoted to captain in 2012.[1] McMaster is a senior clinical trial specialist.[1] She researches Waldenström macroglobulinemia, lymphoproliferative disorders, testicular cancer, and DICER1 syndrome.[1] McMaster presents at International Waldenstrom's Macroglobulinemia Foundation meetings.[2]
See also
editReferences
edit- ^ a b c d e f g h i "Mary L. McMaster, M.D., biographical sketch and research interests - NCI". dceg.cancer.gov. 1980-01-01. Retrieved 2022-10-18. This article incorporates text from this source, which is in the public domain.
- ^ "Mary McMaster, MD Presentations". International Waldenstrom’s Macroglobulinemia Foundation. Retrieved 2022-10-18.